0B68 Trabulsi, Edouard - Thomas Jefferson University - Thomas Jefferson University

Edouard Trabulsi, MD

Contact Dr. Trabulsi

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
  2. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
  3. Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: Comparative analysis of long-term outcomes
  4. Treatment of Exophytic Renal Cancer Smaller than 3 cm: Surgery versus Active Surveillance
  5. Cutaneous metastasis of micropapillary urothelial carcinoma
  6. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy
  7. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: Results of a multicenter phase II study with molecular correlates of response and toxicity
  8. High dose rate brachytherapy boost for prostate cancer: A systematic review
  9. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  10. Characterization of renal masses with harmonic and subharmonic contrast-enhanced ultrasound
  11. Implementing Hexaminolevulinate HCl Blue LightCystoscopy: A Nursing Perspective
  12. Surgical suturing training with virtual reality simulation versus dry lab practice: an evaluation of performance improvement, content, and face validity
  13. The effects of fatigue on robotic surgical skill training in Urology residents
  14. Impact of NADiA ProsVue PSA slope on secondary treatment decisions after radical prostatectomy
  15. Predictors of positive surgical margins after radical prostatectomy at a single institution: Preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location
  16. Patterns of care for elderly men diagnosed with favorable-risk prostate cancer from 2004 to 2008 : A population-based analysis
  17. Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications.
  18. Targeting cell cycle and hormone receptor pathways in cancer
  19. Pharmacologic inhibition of Jak2-Stat5 signaling by Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer
  20. Evolution of advanced technologies in prostate cancer radiotherapy